Daratumumab to Treat Active Lupus Nephritis
NCT04868838
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Lupus Nephritis
Interventions
DRUG:
Daratumumab
Sponsor
Mayo Clinic